Epistem completes board line up and launches new NGS service
Epistem Limited, the Manchester based pre-clinical and clinical research services company announces the completion of its Board appointments. Investment from the Foresight group in June 2018 enabled expansion of the research services, the first of which is launched in December 2018 - GCLP compliant Next Generation Sequencing (NGS) services.
10 Years GCLP Accreditation at Epistem
We are pleased to announce the successful GCLP re-accreditation of our laboratories.
Epistem completes management buyout
Epistem, the Manchester UK-based Contract Research Company, announces that following investment by Foresight Group it has completed a management buy-out ("MBO") from genedrive plc.